Doctor groups have long been warned against accepting drug company sponsorship in case they are influenced, but a Fairfax Media analysis has found one particular organisation is aggressively seeking financial support, collecting close to $1 million in six months.
The Haematology Society of Australia and New Zealand (HSANZ) and its sub-groups received $972,000 in 50 separate payments from 17 pharmaceutical companies, including Roche, Amgen and Novartis, between May and October last year. Sydney Morning Herald – Read more…